(Q28165743)

title

Hepatocellular damage from non-steroidal anti-inflammatory drugs (English)

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566034

22 March 2024

author name string

N. O'Connor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566034

22 March 2024

P. I. Dargan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566034

22 March 2024

A. L. Jones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566034

full work available at URL

22 March 2024

language of work or name

English

0 references

publication date

November 2003

0 references

published in

QJM: An International Journal of Medicine

0 references

volume

96

0 references

issue

11

0 references

page(s)

787-91

0 references

cites work

Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Incidence of drug-induced hepatic injuries: a French population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Paracetamol pack size restriction: the impact on paracetamol poisoning and the over-the-counter supply of paracetamol, aspirin and ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Asymptomatic diclofenac-induced acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Update of hepatotoxicity due to classes of drugs in common clinical use: non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Acute hepatocellular and cholestatic injury in a patient taking celecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Fatal hepatoxicity secondary to nimesulide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Rofecoxib-induced cholestatic hepatitis: treatment with molecular adsorbent recycling system (MARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

The natural history of histologically proved drug induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Fulminant hepatic failure due to diclofenac treated successfully by orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Inadvertent diclofenac rechallenge from generic and non-generic prescribing, leading to liver transplantation for fulminant liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

A possible mechanism of naproxen-induced lipid peroxidation in rat liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Criteria of drug-induced liver disorders. Report of an international consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Recent advances in the management of late paracetamol poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG138

Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus

21 January 2018

https://api.crossref.org/works/10.1093/QJMED/HCG138

9

1 reference

Orthotopic liver transplantation after subacute liver failure induced by therapeutic doses of ibuprofen

22 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG138

10

1 reference

Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series

22 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG138

11

1 reference

Fatal fulminant hepatitis associated with bromfenac use

22 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG138

14

1 reference

Celecoxib-induced cholestatic hepatotoxicity in a patient with cirrhosis

22 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG138

17

1 reference

The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib

22 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG138

19

1 reference

Oxaprozin-induced fulminant hepatitis

22 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG138

22

1 reference

Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation. The Acute Liver Failure Study Group

22 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG138

25

1 reference

Effects of non-narcotic analgesics on the liver

22 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG138

34

1 reference